Clinical Trials Directory

Trials / Sponsors / Blue Earth Diagnostics

Blue Earth Diagnostics

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Recruiting[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer
Phase 1 / Phase 22026-03-18
CompletedIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in
Prostate Cancer
Phase 42024-12-04
CompletedStudy to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
Brain Metastases
Phase 32020-10-26
CompletedStudy to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metasta
Brain Metastases
Phase 22020-08-31
CompletedImaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prost
Prostate Cancer
Phase 32020-05-04
CompletedImaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Pros
Prostate Cancer
Phase 32020-03-02
CompletedAssessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subject
Prostate Cancer
Phase 12019-06-11
Completed18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment
Prostate Cancer
Phase 32016-06-01
CompletedFluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer
Cancer of the Prostate
Phase 32015-11-01
CompletedRetrospective Observational Study Investigating Fluciclovine (18F) (FACBC)
Prostatic Neoplasms
—2015-01-01